CA1092303A - No translation available - Google Patents

No translation available

Info

Publication number: CA1092303A
Authority: CA; Canada
Prior art keywords: vascular graft; tube; graft; porous; subsurface
Prior art date: 1976-05-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA259,054A

Other languages

English (en)

Inventor

David C. Macgregor

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-05-05

Filing date

1976-08-13

Publication date

1980-12-30

1976-05-05 Priority claimed from US05/683,382 external-priority patent/US4101984A/en

1976-08-13 Application filed by Individual filed Critical Individual

1977-08-15 Priority claimed from US05/824,296 external-priority patent/US4281669A/en

1979-11-19 Priority to US06/095,151 priority Critical patent/US4374669A/en

1980-09-19 Priority to CA360,677A priority patent/CA1105652A/fr

1980-12-30 Application granted granted Critical

1980-12-30 Publication of CA1092303A publication Critical patent/CA1092303A/fr

1982-02-23 Priority to US06/351,526 priority patent/US4459252A/en

1983-06-30 Priority to US06/486,796 priority patent/US4627836A/en

1986-12-08 Priority to US06/924,060 priority patent/US4936317A/en

Status Expired legal-status Critical Current

Links

230000002792 vascular Effects 0.000 title claims abstract description 38
239000000463 material Substances 0.000 title claims abstract description 13
239000011148 porous material Substances 0.000 claims abstract description 37
239000012530 fluid Substances 0.000 claims abstract description 9
230000015572 biosynthetic process Effects 0.000 claims abstract description 7
229920000642 polymer Polymers 0.000 claims description 19
239000002245 particle Substances 0.000 claims description 17
239000004744 fabric Substances 0.000 claims description 15
238000000034 method Methods 0.000 claims description 13
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
210000004369 blood Anatomy 0.000 claims description 10
239000008280 blood Substances 0.000 claims description 10
238000005266 casting Methods 0.000 claims description 8
230000001427 coherent effect Effects 0.000 claims description 6
230000000541 pulsatile effect Effects 0.000 claims description 5
239000011780 sodium chloride Substances 0.000 claims description 5
239000012779 reinforcing material Substances 0.000 claims description 4
230000036772 blood pressure Effects 0.000 claims description 3
230000002787 reinforcement Effects 0.000 claims description 3
239000007787 solid Substances 0.000 claims description 3
239000006185 dispersion Substances 0.000 claims description 2
239000002904 solvent Substances 0.000 claims description 2
239000000758 substrate Substances 0.000 claims description 2
239000010410 layer Substances 0.000 claims 12
230000004872 arterial blood pressure Effects 0.000 claims 4
230000003872 anastomosis Effects 0.000 claims 1
230000015556 catabolic process Effects 0.000 claims 1
239000013047 polymeric layer Substances 0.000 claims 1
208000007536 Thrombosis Diseases 0.000 abstract description 3
230000001464 adherent effect Effects 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
210000001519 tissue Anatomy 0.000 description 7
229910052751 metal Inorganic materials 0.000 description 5
239000002184 metal Substances 0.000 description 5
210000003709 heart valve Anatomy 0.000 description 4
229920004934 Dacron® Polymers 0.000 description 3
208000005189 Embolism Diseases 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
239000011521 glass Substances 0.000 description 3
239000005020 polyethylene terephthalate Substances 0.000 description 3
230000009424 thromboembolic effect Effects 0.000 description 3
239000003146 anticoagulant agent Substances 0.000 description 2
229940127219 anticoagulant drug Drugs 0.000 description 2
238000001035 drying Methods 0.000 description 2
238000010828 elution Methods 0.000 description 2
239000000945 filler Substances 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
238000007654 immersion Methods 0.000 description 2
229920002635 polyurethane Polymers 0.000 description 2
239000004814 polyurethane Substances 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
230000002885 thrombogenetic effect Effects 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
241000272522 Anas Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
235000003332 Ilex aquifolium Nutrition 0.000 description 1
235000002296 Ilex sandwicensis Nutrition 0.000 description 1
235000002294 Ilex volkensiana Nutrition 0.000 description 1
239000004721 Polyphenylene oxide Substances 0.000 description 1
208000001435 Thromboembolism Diseases 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000023555 blood coagulation Effects 0.000 description 1
238000009835 boiling Methods 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
239000013078 crystal Substances 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000012156 elution solvent Substances 0.000 description 1
230000003511 endothelial effect Effects 0.000 description 1
-1 fibres Substances 0.000 description 1
229920002457 flexible plastic Polymers 0.000 description 1
239000012634 fragment Substances 0.000 description 1
208000007475 hemolytic anemia Diseases 0.000 description 1
230000001788 irregular Effects 0.000 description 1
238000002386 leaching Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
229920000570 polyether Polymers 0.000 description 1
229920000307 polymer substrate Polymers 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
239000012744 reinforcing agent Substances 0.000 description 1
230000003014 reinforcing effect Effects 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
230000009772 tissue formation Effects 0.000 description 1
239000011345 viscous material Substances 0.000 description 1
239000002759 woven fabric Substances 0.000 description 1

Landscapes

Materials For Medical Uses (AREA)
Prostheses (AREA)

CA259,054A 1975-05-09 1976-08-13 No translation available Expired CA1092303A (fr)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
US06/095,151 US4374669A (en)	1975-05-09	1979-11-19	Cardiovascular prosthetic devices and implants with porous systems
CA360,677A CA1105652A (fr)	1976-05-02	1980-09-19	Structure de valvule cardiaque
US06/351,526 US4459252A (en)	1975-05-09	1982-02-23	Method of forming a small bore flexible vascular graft involving eluting solvent-elutable particles from a polymeric tubular article
US06/486,796 US4627836A (en)	1975-05-09	1983-06-30	Cardiovascular prosthetic devices and implants with porous systems
US06/924,060 US4936317A (en)	1975-05-09	1986-12-08	Cardiovascular prosthetic devices and implants with porous systems

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US683,382		1976-05-02
US05/683,382 US4101984A (en)	1975-05-09	1976-05-05	Cardiovascular prosthetic devices and implants with porous systems
US824,296		1976-08-15
US05/824,296 US4281669A (en)	1975-05-09	1977-08-15	Pacemaker electrode with porous system

Publications (1)

Publication Number	Publication Date
CA1092303A true CA1092303A (fr)	1980-12-30

Family

ID=27103092

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA259,054A Expired CA1092303A (fr)	1975-05-09	1976-08-13	No translation available

Country Status (1)

Country	Link
CA (1)	CA1092303A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4604762A (en) *	1981-02-13	1986-08-12	Thoratec Laboratories Corporation	Arterial graft prosthesis
US4871361A (en) *	1987-02-26	1989-10-03	Kanegafuchi Kagaku Kogyo Kabushiki Kaisha	Artificial vessel
US5081161A (en) *	1990-06-15	1992-01-14	E. I. Du Pont De Nemours And Company	Process for making shaped articles of a thermoplastic resin having a microcellular structure

1976
- 1976-08-13 CA CA259,054A patent/CA1092303A/fr not_active Expired

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4604762A (en) *	1981-02-13	1986-08-12	Thoratec Laboratories Corporation	Arterial graft prosthesis
US4731073A (en) *	1981-02-13	1988-03-15	Thoratec Laboratories Corporation	Arterial graft prosthesis
US4871361A (en) *	1987-02-26	1989-10-03	Kanegafuchi Kagaku Kogyo Kabushiki Kaisha	Artificial vessel
US5081161A (en) *	1990-06-15	1992-01-14	E. I. Du Pont De Nemours And Company	Process for making shaped articles of a thermoplastic resin having a microcellular structure

Legal Events

Date	Code	Title	Description
1997-12-30	MKEX	Expiry

Publication	Publication Date	Title
US4725273A (en)	1988-02-16	Artificial vessel having excellent patency
EP0157178B1 (fr)	1988-11-30	Vaisseau artificiel et procédé pour sa préparation
EP2819716B1 (fr)	2018-04-25	Surfaces biocompatibles perfectionnées et dispositifs incorporant de telles surfaces
US5037377A (en)	1991-08-06	Means for improving biocompatibility of implants, particularly of vascular grafts
US5632776A (en)	1997-05-27	Implantation materials
CA1240805A (fr)	1988-08-23	Prothese vasculaire
US5549664A (en)	1996-08-27	Artificial blood vessel
US5387236A (en)	1995-02-07	Vascular prosthesis, manufacturing method of the same, and substrate for vascular prosthesis
CA1341519C (fr)	2007-01-02	Greffe vasculaire
AU685441B2 (en)	1998-01-22	Tissue equivalents
EP0248246B1 (fr)	1990-09-19	Paroi artificielle pour vaisseau
US5383927A (en)	1995-01-24	Non-thromogenic vascular prosthesis
CA1207105A (fr)	1986-07-08	Prothese pour greffes arterielles
Bascom	1961	Gelatin sealing to prevent blood loss from knitted arterial grafts
CA2074362A1 (fr)	1992-05-23	Materiel d'implantation
Dreyer et al.	1960	Aortic grafts of polyurethane in dogs
US4871361A (en)	1989-10-03	Artificial vessel
Guidoin et al.	1983	Polyester prostheses as substitutes in the thoracic aorta of dogs. I. Evaluation of commercial prostheses
US4986832A (en)	1991-01-22	Artificial blood vessel and process for preparing it
EP0495127B1 (fr)	1996-11-27	Vaisseau sanguin artificiel et procede de production associe
EP0217115B1 (fr)	1989-10-25	Vaisseau artificiel
JPH05500912A (ja)	1993-02-25	ポリマー製品
WO2000018321A1 (fr)	2000-04-06	Vaisseaux sanguins synthetiques hydrophiles
JPH04187154A (ja)	1992-07-03	人工血管およびパッチ
Mori	1989	Vascular graft materials and their structure